477 related articles for article (PubMed ID: 18805020)
1. Anti-Müllerian hormone and ovarian dysfunction.
Broekmans FJ; Visser JA; Laven JS; Broer SL; Themmen AP; Fauser BC
Trends Endocrinol Metab; 2008 Nov; 19(9):340-7. PubMed ID: 18805020
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
3. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
[TBL] [Abstract][Full Text] [Related]
4. Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
[TBL] [Abstract][Full Text] [Related]
5. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
[TBL] [Abstract][Full Text] [Related]
6. Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.
Uzumcu M; Kuhn PE; Marano JE; Armenti AE; Passantino L
J Endocrinol; 2006 Dec; 191(3):549-58. PubMed ID: 17170213
[TBL] [Abstract][Full Text] [Related]
7. [The anti-mullerian hormone--physiology and application into clinical practice].
Robeva R; Mekhandzhiev Ts; Tomova A; Kumanov F
Akush Ginekol (Sofiia); 2006; 45(7):50-4. PubMed ID: 17489169
[TBL] [Abstract][Full Text] [Related]
8. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
Das M; Gillott DJ; Saridogan E; Djahanbakhch O
Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
[TBL] [Abstract][Full Text] [Related]
9. [Anti-Mullerian hormone and polycystic ovary syndrome].
Catteau-Jonard S; Dewailly D
Gynecol Obstet Fertil; 2011 Sep; 39(9):514-7. PubMed ID: 21840745
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
La Marca A; Volpe A
Clin Endocrinol (Oxf); 2006 Jun; 64(6):603-10. PubMed ID: 16712660
[TBL] [Abstract][Full Text] [Related]
11. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
[TBL] [Abstract][Full Text] [Related]
12. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone and polycystic ovary syndrome.
Bhide P; Homburg R
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
[TBL] [Abstract][Full Text] [Related]
15. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions].
Yu M; Deng CY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
Pigny P; Merlen E; Robert Y; Cortet-Rudelli C; Decanter C; Jonard S; Dewailly D
J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels.
Panidis D; Katsikis I; Karkanaki A; Piouka A; Armeni AK; Georgopoulos NA
Med Hypotheses; 2011 Oct; 77(4):649-53. PubMed ID: 21807466
[TBL] [Abstract][Full Text] [Related]
18. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
20. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
